Florida Cancer Specialists

1630 Southeast 18th Street
Ocala, Florida 34471

We've found

1 trials

at this facility

A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Ocala, FL

Use our guide to learn which trials are right for you!